IP Library › Granted Patent US 8,080,639
Granted Patent B2
US 8,080,639 · App. 11/981,260 · Granted Dec 20, 2011

Antibodies which bind specifically to activin receptor like kinase 3

Assignee: Ludwig Institute for Cancer Research
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,080,639
App. No.
11/981,260
Granted
Dec 20, 2011
Kind
B2
Abstract

A new receptor family has been identified, of activin-like kinases. Novel proteins have activin/TGF-β-type I receptor functionality, and have consequential diagnostic/therapeutic utility. They may have a serine/threonine kinase domain, a DFKSRN or DLKSKN sequence in subdomain VIB and/or a GTKRYM sequence in subdomain VIII.

Claims (4)

1. An isolated antibody which binds specifically to an amino acid sequence encoded by the nucleotide sequence set forth in SEQ ID NO: 5 (ALK-3).

2. The isolated antibody of claim 1 , wherein the antibody bind specifically to the amino sequence of SEQ ID NO: 6.

3. The isolated antibody of claim 1 , wherein the antibody binds specifically to an extracellular domain of a human protein encoded by the nucleotide sequence set forth in SEQ ID NO: 5.

4. The isolated antibody of claim 1 , wherein the antibody binds specifically to amino acids 181-202 of SEQ ID NO: 6.

Priority Claims (7)
GB 9224057.1 · Nov 17, 1992 · national
GB 9304677.9 · Mar 8, 1993 · national
GB 9304680.3 · Mar 8, 1993 · national
GB 9311047.6 · May 28, 1993 · national
GB 9313763.6 · Jul 2, 1993 · national
GB 9136099.2 · Aug 3, 1993 · national
GB 9321344.5 · Oct 15, 1993 · national
Continuity (6)
Continuation 11656720 · Jan 23, 2007
Division 10630555 · Jul 30, 2003
Division 09903068 · Jul 11, 2001
Division 09679187 · Oct 3, 2000
Division 08436265
Related Publication 20100330657A1 · Dec 30, 2010